MS275
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MS275, covering 2024-05-28 to 2024-05-28. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML) [Phase 2]